Seeking Alpha

Yabadabadoo

Yabadabadoo
Send Message
View as an RSS Feed
View Yabadabadoo's Comments BY TICKER:
Latest comments  |  Highest rated
  • Medical Marijuana, Inc: Definitely A Dope Opera [View article]
    Even though I am an owner of MJNA, I do not recommend buying until we hear good news or should I say any news from them.

    Even if the stock goes lower, do not buy until you hear solid good news.
    Nov 18 07:20 AM | 5 Likes Like |Link to Comment
  • How Management Misled Investors When It Gained Control Of Medical Marijuana, Inc. [View article]
    As I said in my comments yesterday, an investor must be patient and listen to all views and make your decision based on your research.
    You now have another place to look. MJNA came out with a very informative and long statement. My recommendation is you read and then make your decision. As I said yesterday, I was holding until I could find more info on the stock.
    A company that may be involved in unethical practices most likely would not come out with a statement. At this time I have no intention of selling my position.
    Apr 30 11:58 AM | 5 Likes Like |Link to Comment
  • Housing: Still Flooded [View article]
    Excellent article.
    For those like me who own their house for 30 years, we are very much ahead but for anyone that bought in the in the last 10 years, they are not. I am conerened that our children and their children are going to be worsr off than we are. I never thought I would say that.
    I am a day trader and listen to anaylst each day and wonder if some of them are living in a fantasy world. I do not see the housing market coming back for years; prices will continue to fall and foreclosure will rise as long as potential owners are allowed to put down less than 20%. Not everyone can afford a house and even less today can afford to purchase. There is nothing wrong with renting.
    Our unemployment is at approx 17% and not the 9.5% that we keep seeing. And those that may start finding jobs will get paid a much lower salary or get temp jobs without benefits.
    I look at our politicians and wonder how they could believe that people that put down less than 20% could afford that home. Prices always go up, taxes, insurance, utilities, food, etc. They are the ones that started this situation and then followed by the mortgage brokers offering 100% mortgages. Our polticians are the ones to blame; not Wall street or the banks. They are the ones to forced the banks to lend to those that cannot afford, do not forget Fannie and Freddie Mac.
    I can see banks maybe renegotiating the rates to help the owners but only if the banks believe that by lowering the rates those owners will be able to afford. What I am against is the gov't giving money to reduce the principal. That is unfair to the vast majority of people who have been and continue to pay their mortgages on time. By the gov't continuing to increase our debt will only cause our taxes and fees to increase causing many of those, that are paying on time, to possibly default on their mortgage.
    When the gov't looks to tax businesses to cover the gov'ts mistakes, the businesses will not hurt but we will as they pass their tax increases to us, the consumers.
    You may see those that can afford start going under if the gov't looks to bail everyone out. We just cannot afford it any longer. It appears the our politicians believe we are a bottomless pit.
    Aug 6 03:05 PM | 4 Likes Like |Link to Comment
  • 3 Near-Term Drivers For Medical Marijuana, Inc. [View article]
    As a stock holder I am concerned about the lack of information. It appeared from previous news that MJNA was merging, buying and/or partnering with other companies and yet I do not see the positives of all of that information.
    I am one of those that want investors to do the right thing even though I am a stock holder. My recommendation is not to buy until you hear positive news directly from the company; if any one else gives positive news then they are only looking to artificially raise the price. I am holding my shares.
    Jul 20 06:58 PM | 3 Likes Like |Link to Comment
  • Vivus Is Cheaper Than Arena [View article]
    I can basically take what I just wrote and apply it here. Where were these people when the drugs were still in testing.
    I use common sense in trading and base my trading on past experience. These articles are a little late.

    ARNA will continue moving up and down and as we get closer to their market date. As we get very close, you will see it hit $12. This is just common sense. The stock went to $13.50 when it was approved. $12 is where it will hit and it will probably get another bump when it is out. But just be very careful; it may not get any higher than $13.50 until it can prove itself as being an effective drug.
    OREX is ARNA before approval. Catch it when it is around $5 and sell when it hits $6 - $6.50. It will go up and down for the next 18 months. As we continue to get closer, $5 will be $6 and $6.00 - $6.50 will be $7 and so on unless OREX gets hit with bad news.
    All of these articles will not change my strategy unless I hear actual news from the actual companies or the FDA.
    VVUS will probably move higher when they market their drug but I believe the better value is ARNA and OREX; where you can make the most money.
    I sold a lot of stocks as the market started moving up. Now I wait. Sept and the first half of Oct is not normally good for the market. What is going on the in the Middle East and the market moving higher due to QE3, be prepared for a major hit to take place. Traders know QE3 will do nothing. If the drug stocks follow, that is the perfect time to buy. Just be patient.
    Sep 15 01:36 PM | 3 Likes Like |Link to Comment
  • Assessing Adam Feuerstein's Views On Arena Pharmaceutical's Weight Loss Drug [View article]
    We know what happens to a drug stock like the three up for approval. We will see ups and downs and when we get very close to the date of decision, the stock will start going up.
    The question comes down to who will sell at a profit and who will risk a higher profit or bigger loss waiting until after the decision.
    What bothered me about the article is the quoting of the 10K filing but only quoting the negatives and saying that ARNA is sort of admitting that the drug will not be approved. As you said, all 10Ks will have similar statements. If ARNA felt that way, then ARNA would not have bothered to submit additional info to the FDA. You also have Europe reviewing the drug.
    A well written article looks at the pros and cons and then that person can give their opinion based on facts that we all can see. When only one side is given, regardless of which direction, I believe that is stock manipulation.
    Apr 25 03:38 PM | 3 Likes Like |Link to Comment
  • Assessing Adam Feuerstein's Views On Arena Pharmaceutical's Weight Loss Drug [View article]
    You should not defend a person who only shows the negatives. An objective opinion is to show both the positives and negatives and then give your opinion. He also never stated that in the same filing ARNA provided additional data to the FDA.

    And keep in mind that a research drug company that has no drugs on the market should not even be covered by any analyst. There is nothing to go by other than the results of the drug testing. There are no profits on a company that has nothing to sell.
    If 30 of us reviewed the study, we may get 30 different opinions on why the drug may or may not get approved.
    When someone does not give the pros and the cons, then I believe there is stock manipulation going on.
    Give the pros, give the cons and then give your opinion.
    Apr 25 02:44 PM | 3 Likes Like |Link to Comment
  • Cramer's Mad Money: Ag Is Busting Out All Over (1/13/11) [View article]
    I disagree with Cramer on waiting on AMD. I just purchased it. Their price dropped on the announcement that Meyer left the company. What ever happened to the statement that "we are all replaceable". Look at the reason why he left and you will see the new direction AMD is moving to. They are looking to develop chips for Smart phones and other devices and not just PCs and servers. The Board is looking to expand their business. Once AMD announces who they selected and the direction it will go in, watch the stock move higher.
    Jan 14 12:54 PM | 3 Likes Like |Link to Comment
  • Corinthian Colleges: A Perpetual Mess [View article]
    Excellent article.

    I will take the other side and be bullish on COCO. I do own it and have made money on it. They have stated that they would not do well until the second half of 2014 and I will take their side for now.
    They have eliminated the campuses that have not done well and I want to see what happens in 2014. Regarding lawsuits, the only way California brings in money is on lawsuits; sometimes cheaper to settle than fight.

    Other schools have closed; one recently bought and there are not many jobs out there for the traditional four year degrees. Software, faster computers, take overs, etc. are reducing the number of traditional white collar jobs. So what is left, schools like COCO, Community Colleges and four year colleges with night programs that involve certifications rather than degree programs. So I wait and see but again excellent detailed article.

    Nov 12 09:23 PM | 2 Likes Like |Link to Comment
  • Corinthian Colleges: 38% Downside, A Great Short Play [View article]
    My recommendation is for those reading this article is to listen or read the last qtr.'s meeting. Long term, stock is looking good.
    These profit institutions offer more courses that are associated with community colleges. Unfortunately more jobs are leaning toward students receiving certifications rather than BA degrees.
    Nice to have the degree but four year colleges are not preparing students for jobs.
    Also you need to look at other factors. Obama care will force much more layoffs in addition to the normal mergers and mechanization that brings about layoffs.
    Many of those people will already have degrees and will need to go to these profit schools to learn a trade, programming, etc.
    Many have lost their money trying to short a stock. Read more about Corinthian, from their site, before making your decision.
    Sep 23 11:36 AM | 2 Likes Like |Link to Comment
  • 3 Near-Term Drivers For Medical Marijuana, Inc. [View article]
    I have not received that letter but still does not change what I said above. Signing it as "The Team at MJNA" does not tell me who is putting that statement out.
    Regarding their statement on affordability, that would make it into the news. Even one of the obesity drug companies announced a reduction in price and that made it in the news when you went into their site.
    As a stock holder, I want this stock to grow but I cannot recommend until I see their news when I am viewing my account.
    At this point, their marketing campaign is awful if they are only looking to target those seeking them out. You market to all and that is how to attract those that are unaware of MJNA.
    I know marketing and this is amateur marketing.
    You received the letter above and I have not and yet I have thousands of shares. There is something wrong. We wait and see.
    Jul 28 01:18 PM | 2 Likes Like |Link to Comment
  • 3 Near-Term Drivers For Medical Marijuana, Inc. [View article]
    Remember the comments made by Michelle Sides, Chairman, Chief Operating Officer and Shareholder on April 30 2013. She came out against all of the negative comments made against MJNA. Where is she today; no comments from her. When I go into their news and all I see is news on another marijuana stock.
    As I said earlier, I am a stock holder and would never recommend anyone buy if this stocks actually slips to 2-3 cent range. It does not make sense with all of the positive news on marijuana and the stock market at all time highs. We need to hear from the COO.
    As an Apple holder, I have no problem with their silence, they pay a dividend and they always come out with new devices as we get closer to the holidays.
    We need news directly from MJNA.
    Jul 26 12:27 PM | 2 Likes Like |Link to Comment
  • Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? [View article]
    You wrote an excellent article. I listened to the call hoping that traders would bring the stock down so I can buy more for my family. Between yesterday and today, I added another 6500 shares to my brother and sons' account.
    Traders need to look at the future of ALXA. You allowed traders to do their homework and make their decision.
    My opinion, I am long looking at the 1st qtr. of 2014 to watch this stock go above $10.
    I have owned TEVA for many years and they do like to buy other pharmas. But now they are partnering with ALXA and that is just as good. Common sense says this stock will double within a year.
    For those reading my comments, I am fully in with different stocks and have no additional money to buy more for myself but I do own a tremendous amount of ALXA and have no problem holding this stock. Do your research before buying and make sure you are willing to wait. For me, this was an easy pick. Use common sense when trading and keep out the emotions.
    Again, very good article and hope most people will go back and listen to the call.
    May 15 10:47 AM | 2 Likes Like |Link to Comment
  • Cramer's Lightning Round - I Am Not In Love With Arena (2/5/13) [View article]
    I have been following and buying and selling ARNA for the last 2.5 years. I do not disagree with Cramer.
    ARNA's stock price will rise when it starts selling its' drug but they are no longer a speculative stock to play with. Their stock price will now be based on earnings. Their earnings for the first two qtrs. from the start of their sales will be low.
    At this time I agree with Cramer and at the same time I agree that Cramer has been wrong.
    I have made my money from ARNA and currently do not own.
    If traders want to wait, the time to buy is when they announce their earnings in March. They will not have any earnings, people panic and sell, price goes down and that is my time to buy.
    Feb 6 10:42 AM | 2 Likes Like |Link to Comment
  • The FDA's approval of Alexza Pharmaceutical's (ALXA) Adasuve comes with several post-approval requirements, including a large observational clinical trial to gather patient safety data based on real-world use, as well as a clinical program addressing the safety and efficacy of the drug adolescent patients. Shares -11% AH. [View news story]
    FDA appears to be asking for post approval results on other new drugs. Nothing wrong with that. It will prove what we all know; using an old drug in a new way will have very few situations occurring.
    I feel bad for those that may have sold after market. This stock will mover higher. A lot to offer with another 200 drugs that they have identified as possible candidates for Adasuve.
    Dec 21 08:33 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
428 Comments
112 Likes